Get started
Author

Megan K. Herbert

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology
2019 · Claire Bridel, Wessel N. van Wieringen, et al. · JAMA Neurology · 796
PDF
Arsenic targets Pin1 and cooperates with retinoic acid to inhibit cancer-driving pathways and tumor-initiating cells
2018 · Shingo Kozono, Yu-Min Lin, et al. · Nature Communications · 170
PDF
Cis P-tau is induced in clinical and preclinical brain injury and contributes to post-injury sequelae
2017 · Onder Albayram, Asami Kondo, et al. · Nature Communications · 154
PDF
Disease specificity of autoantibodies to cytosolic 5′-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases
2015 · Megan K Herbert, Judith Stammen-Vogelzangs, et al. · Annals of the Rheumatic Diseases · 145
PDF
Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis
2017 · J B Lilleker, A Rietveld, et al. · Annals of the Rheumatic Diseases · 88
PDF
CSF levels of DJ-1 and tau distinguish MSA patients from PD patients and controls
2013 · Megan K. Herbert, Jorine M. Eeftens, et al. · Parkinsonism & Related Disorders · 84
CSF Neurofilament Light Chain but not FLT3 Ligand Discriminates Parkinsonian Disorders
2015 · Megan K. Herbert, Marjolein B. Aerts, et al. · Frontiers in Neurology · 79
PDF
Potential of the Antibody Against cis–Phosphorylated Tau in the Early Diagnosis, Treatment, and Prevention of Alzheimer Disease and Brain Injury
2016 · Kun Ping Lu, Asami Kondo, et al. · JAMA Neurology · 74
PDF
Cis P-tau underlies vascular contribution to cognitive impairment and dementia and can be effectively targeted by immunotherapy in mice
2021 · Chenxi Qiu, Onder Albayram, et al. · Science Translational Medicine · 65
Immune‐Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA–DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum
2017 · Simon Rothwell, Robert G. Cooper, et al. · Arthritis & Rheumatology · 59
PDF
Function and regulation of tau conformations in the development and treatment of traumatic brain injury and neurodegeneration
2016 · Onder Albayram, Megan K. Herbert, et al. · Cell & Bioscience · 58
PDF
Identification of clinical disease trajectories in neurodegenerative disorders with natural language processing
2024 · Nienke J. Mekkes, Minke Groot, et al. · Nature Medicine · 47
PDF
CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSD
2020 · Iris Kleerekooper, Megan K Herbert, et al. · Journal of Neurology Neurosurgery & Psychiatry · 35
PDF
Pin1 inhibition exerts potent activity against acute myeloid leukemia through blocking multiple cancer-driving pathways
2018 · Xiaolan Lian, Yu-Min Lin, et al. · Journal of Hematology & Oncology · 32
PDF
Addition of MHPG to Alzheimer's disease biomarkers improves differentiation of dementia with Lewy bodies from Alzheimer's disease but not other dementias
2013 · Megan K. Herbert, Marjolein B. Aerts, et al. · Alzheimer s & Dementia · 28
Novel serology testing for sporadic inclusion body myositis
2015 · Megan K. Herbert, Ger J.M. Pruijn · Current Opinion in Rheumatology · 23
Enantioselective assay for the determination of perhexiline enantiomers in human plasma by liquid chromatography
2006 · Benjamin J. Davies, Megan K. Herbert, et al. · Journal of Chromatography B · 18
Levels of HVA, 5-HIAA, and MHPG in the CSF of vascular parkinsonism compared to Parkinson’s disease and controls
2013 · Megan K. Herbert, H. Bea Kuiperij, et al. · Journal of Neurology · 17
Total glutamine synthetase levels in cerebrospinal fluid of Alzheimer's disease patients are unchanged
2014 · Nienke M. Timmer, Megan K. Herbert, et al. · Neurobiology of Aging · 16
PDF
Limited expression of heparan sulphate proteoglycans associated with Aβ deposits in the APPswe/PS1dE9 mouse model for Alzheimer's disease
2010 · N. M. Timmer, M. K. Herbert, et al. · Neuropathology and Applied Neurobiology · 14
PDF
Investigating Crimean–Congo haemorrhagic fever virus seropositivity in camels and human behavioural risks in an abattoir in Nigeria
2024 · Andrew Musa Adamu, Anyebe Bernard Onoja, et al. · Epidemiology and Infection · 13
PDF
Determination of the 4-monohydroxy metabolites of perhexiline in human plasma, urine and liver microsomes by liquid chromatography
2006 · B DAVIES, M HERBERT, et al. · Journal of Chromatography B · 12
Effect of CYP2D6 metabolizer status on the disposition of the (+) and (−) enantiomers of perhexiline in patients with myocardial ischaemia
2007 · Sally C. Inglis, Megan K. Herbert, et al. · Pharmacogenetics and Genomics · 10
Steady‐state pharmacokinetics of the enantiomers of perhexiline in CYP2D6 poor and extensive metabolizers administered Rac‐perhexiline
2007 · Benjamin J. Davies, Megan K. Herbert, et al. · British Journal of Clinical Pharmacology · 9
PDF
Optimisation of the quantification of glutamine synthetase and myelin basic protein in cerebrospinal fluid by a combined acidification and neutralisation protocol
2012 · Megan K. Herbert, H. Bea Kuiperij, et al. · Journal of Immunological Methods · 5
Works count: 32
Citation count: 2,062
H-index: 17
I10-index: 23
Year
Topic
Type